Browsing Tag

immunogenicity

Vaccine Against Chikungunya in Making

ISW Desk Aug 27, 2021 0

A new weapon against the debilitating infection of Chikungunya could soon be in the offing. A multi-country Phase II/III clinical trial of a vaccine led by the International Vaccine Institute (IVI) in partnership with Bharat Biotech…
Read More...

News

First mRNA-Based COVID 19 Vaccine Gets Nod for Phase II/III Trial

Team DP Aug 25, 2021 0

The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial…
Read More...

News

Potential Game-Changer Indian Vaccine for COVID-19

ISW Desk Aug 25, 2021 0

A new chapter in the fight against the ongoing epidemic of COVID-19 has begun with the Drug Controller General of India (DCGI) giving the approval for Emergency Use Authorization (EUA) for the world’s first and India’s indigenously…
Read More...

Our Campaigns

Support & Donate Now

The role of journalism is strongly challenged now more than ever before. It is imperative that the fourth pillar of democracy publish news and views in its most credible form. We at Delhi Post place the highest regard for freedom of expression. We strive to publish the truth and assert credibility over chaos. To safeguard the independent, non-partisan space, we depend on the support of our readers and contributors. Please Donate Now and join us in maintaining this platform which is a voice for every individual with an opinion!